August 24, 2015
Sendinaden Pattern Breathe Mask
Pharma company Bayer HealthCare has announced the next five startups that will take part in the company's Grants4Apps accelerator program in Germany.
Startups in Bayer's f0ur-month accelerator receive around $58,031 (50,000 euros) and coaching from Bayer executives as well as other industry experts.
The accelerator's first class was announced in August last year...
August 19, 2015
Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.6 million ($35 million AU) in an initial public offering on the Australian Securities Exchange, including a $3 million investment from its partner pharma company AstraZeneca, which just last month announced a longterm commercialization agreement with the company.
Adherium makes a line of medical devices that...
August 13, 2015
Roche Pharma Research and Early Development, a division of Roche Pharmaceuticals, has developed a new mobile app to measure Parkinson's disease symptoms. The app was developed in partnership with Max Little, a British mathametician at the head of the Parkinson's Voice Initiative, and it will actually be used in a drug development trial with Prothena Biosciences.
“The app is being used in a Phase...
August 3, 2015
Sixty-six percent of all pharma app downloads in the United States, the United Kingdom, and Germany, were downloads of the top 10 apps according to an infographic recently released by German app company SmartPatient (not to be confused with Roni Zeiger-founded online patient community SmartPatients). SmartPatient's iOS and Android app is called MyTherapy.
The Munich-based company analyzed 359...
July 28, 2015
A Junto Health working group meets at the last team summit.
There are a lot of digital health accelerators designed to help startups catch the eye of big pilot partners, but what about the other way around? Last December NYC-based tech accelerator Blueprint Health spun off the Blueprint Health Collective, now renamed Junto Health, to help stakeholders like payers, pharma companies, and...
July 27, 2015
AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.
Adherium's Smartinhaler sends data on when medication was taken to mobile devices and desktop computers via Bluetooth. The platform is designed to help patients, caregivers,...
July 22, 2015
Madison, Wisconsin-based Propeller Health has secured two new FDA clearances for new sensors that are designed to work with two particular inhalers on the market: the Diskus inhaler from GlaxoSmithKline and the Respimat inhaler from Boehringer Ingelheim. Unlike previous FDA clearances for Propeller, the new clearances actually allow Propeller to market its new devices as improving — not just...
July 15, 2015
Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with diabetes if they fall into an insulin coma.
The app helps the user feel prepared to use Glucagon, which is a prescription drug that must be injected. The Glucagon app allows the user to practice the...
July 14, 2015
AstraZeneca has partnered with mobile-enabled health coaching services company Vida to launch an app, called Day-by-Day, that helps patients who are recovering from a heart attack, according to Fortune.
The app is not only designed to speed up the patient's recovery, but it also helps patients deal with trauma that they may feel after experiencing a heart attack. The app is currently part of a...
July 13, 2015
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular.
Last week the...